Published in
Springer (part of Springer Nature), Cell and Tissue Research, 2(385), p. 445-456, 2021
DOI: 10.1007/s00441-021-03479-8
Links
Tools
Nanobodies: new avenue to treat kidney disease
Journal article published in 2021 by
Nicola Wanner 
,
Thomas Eden,
Nastassia Liaukouskaya,
Friedrich Koch-Nolte
,
Thomas Eden,
Nastassia Liaukouskaya,
Friedrich Koch-Nolte
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
AbstractCurrent therapeutic options for renal diseases are limited, and the search for disease-specific treatments is ongoing. Nanobodies, single-domain antibodies with many advantages over conventional antibodies, provide flexible, easy-to-format biologicals with many possible applications. Here, we discuss the potential use of nanobodies for renal diseases.